2. Gene
  3. MICAL2 - Mical2 microtubule associated monooxygenase, calponin and LIM domain containing 2 Gene

MICAL2 - Mical2 microtubule associated monooxygenase, calponin and LIM domain containing 2 Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Rattus norvegicus

Also known as Mical-2; Micalcl; RSB-11-77; RGD1311773

Gene ID: 365352 | Gene type: protein coding

About MICAL2

Summary

Predicted to enable several functions, including FAD binding activity; NAD(P)H oxidase H2O2-forming activity; and mitogen-activated protein kinase binding activity. Predicted to be involved in several processes, including actin filament depolymerization; heart looping; and positive regulation of transcription via serum response element binding activity. Predicted to be located in cytoplasm and nucleus. Orthologous to human MICAL2 (microtubule associated monooxygenase, calponin and LIM domain containing 2). [provided by Alliance of Genome Resources, Apr 2022]

MICAL2 Products(3)

mRNA Protein Name
NM_001139508.2 NP_001132980.1 [F-actin]-monooxygenase MICAL2 isoform 2
NM_001395865.1 NP_001382794.1 [F-actin]-monooxygenase MICAL2 isoform 1
NM_182669.2 NP_872610.2 [F-actin]-monooxygenase MICAL2 isoform 3
Protein Preferred Names Protein Names

[F-actin]-monooxygenase MICAL2

F-actin-monooxygenase MICAL2

ERK2-binding testicular protein 1

MICAL C-terminal like

MICAL C-terminal-like protein

[F-actin]-methionine sulfoxide oxidase MICAL2

ebitein-1

mical-cL

molecule interacting with CasL protein 2

protein MICAL-2

protein-methionine sulfoxide oxidase MI

Related Agents

Clinical Phase
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-P0107 RC-3095 Antagonist / Phase 2
HY-145119S Mindeudesivir 99.02% Phase 1
Pre-clinical Phase
Bioactive Molecules (21)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-107818 4-Hydroxychalcone Inhibitor 99.29% Unkown
HY-103316A Ned 19 Inhibitor 99.92% Unkown
HY-P0107A RC-3095 TFA Antagonist 98.92% Unkown
HY-12736A GSK143 dihydrochloride Inhibitor 99.37% Unkown
HY-109506S DPPC-d62 99.0% Unkown
HY-W010516 2-Methylvaleric acid 99.98% Unkown
HY-W654264 2-Methylbutyrylcarnitine chloride Activator / Unkown
HY-131102 Mequindox Inhibitor 99.62% Unkown
HY-109506S1 DPPC-d9 95.0% Unkown
HY-109506S3 DPPC-d9-1 ≥99.0% Unkown
HY-101139 Xanthine amine congener Antagonist / Unkown
HY-109506S9 DPPC-13C2 95.0% Unkown
HY-12736 GSK143 Inhibitor / Unkown
HY-162720 NNRT-IN-4 Inhibitor / Unkown
HY-B0448S1 Phenytoin-15n2,13c / Unkown
HY-D0195S Acesulfame-d4 potassium / Unkown
HY-RS08426 MICAL2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-109506S2 (Rac)-DPPC-d6 / Unkown
HY-B0281AS Ranitidine-d6 hydrochloride Antagonist 97.00% Unkown
HY-RS20179 Mical2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26683 Mical2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens MICAL2 NCBI NCBI:9645